University of Michigan Board of Regents, Ann Arbor, has approved four investment for its Michigan Investment in New Technology Startups, a venture capital fund co-managed by the university’s investment office and its Office of Technology Transfer. Attercor, a therapy company for adrenal disorders, CytoPherx, a manufacturer of medical devices to treat inflammation-based diseases using a…
The rest of this content is only accessible to Global Venturing Subscribers.
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
